MedTrace Logo

Efficacy of Growth Hormone Supplementation With Gonadotrophins in IVF/ICSI for Poor Responders

NCT03759301 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2019-06-24

No results posted yet for this study

Summary

The objective of this study is to assess the effectiveness of adjuvant growth hormone injection during controlled ovarian stimulation, in poor responder women undergoing intracytoplasmic sperm injection (ICSI) procedures.

Conditions

  • Infertility, Female

Interventions

DRUG

Growth Hormones Somatropin Recombinant

Growth Hormones Somatropin Recombinant 4 IU/day subcutaneous from the 2nd day of the cycle and stopped 1 day before ovum pickup

DRUG

Placebo saline solution

same volume as growth hormone ampule used

Sponsors & Collaborators

  • National Research Centre, Egypt

    collaborator OTHER

  • ClinAmygate

    lead OTHER

Principal Investigators

  • Mohamed M Shafeek, MSc · Al-Azhar University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
38 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-20
Primary Completion
2019-05-05
Completion
2019-06-05

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03759301 on ClinicalTrials.gov